Sofia Broco
YOU?
Author Swipe
View article: The impact of CDK4/6 inhibitors on the quality of life of working-age women with metastatic breast cancer: a population-based cohort study from Portugal
The impact of CDK4/6 inhibitors on the quality of life of working-age women with metastatic breast cancer: a population-based cohort study from Portugal Open
Background Breast cancer frequently leads to reduced work capacity and increased absenteeism among working-age women diagnosed with this condition. In this study, we aimed to assess the effect of CDK4/6i combined with aromatase inhibitors …
View article: Immune Response to SARS-CoV-2 Vaccination in Cancer Patients: A Prospective Study
Immune Response to SARS-CoV-2 Vaccination in Cancer Patients: A Prospective Study Open
Introduction Cancer patients on active treatment are at increased risk of developing coronavirus disease 2019 (COVID-19), making effective immunization of the utmost importance. However, the effectiveness of vaccination in this population …
View article: An observational cross-sectional study on breast cancer patients’ knowledge of their disease: A likely cause of depression and anxiety
An observational cross-sectional study on breast cancer patients’ knowledge of their disease: A likely cause of depression and anxiety Open
Background: This study aimed to assess breast cancer awareness among patients undergoing active treatment for breast cancer at Day Hospital, assess their quality of life (QoL), and explore the association between minor knowledge of the dis…
View article: Epithelioid Trophoblastic Tumour Presenting with Scalp Lesions
Epithelioid Trophoblastic Tumour Presenting with Scalp Lesions Open
Epithelioid trophoblastic tumour (ETT) is a very rare variant of gestational trophoblastic disease, which arises in reproductive-age women with a prior gestational history. Because of its rarity, its biological behaviour, imaging character…
View article: 732 Ovarian cancer and BRCA1 and 2 germline mutations – the Portuguese experience
732 Ovarian cancer and BRCA1 and 2 germline mutations – the Portuguese experience Open
Introduction/Background* Ovarian cancer (OC) is the second most common gynecologic malignancy in developed countries and the third most common in developing countries. Approximately 13 to 15 percent of OC are attributable to heritable muta…
View article: Prognostic factors for early relapse in non-metastatic triple negative breast cancer — real world data
Prognostic factors for early relapse in non-metastatic triple negative breast cancer — real world data Open
In this real-life non-metastatic TNBC cohort, neoadjuvant radiotherapy (performed due to insufficient clinical response to neoadjuvant chemotherapy or significant toxicity) impacted as an independent prognostic factor for relapse along wit…